trending Market Intelligence /marketintelligence/en/news-insights/trending/jwaicwzj5outcxx6x1lblq2 content esgSubNav
In This List

Clearside Biomedical chairperson steps down; replacement appointed

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Clearside Biomedical chairperson steps down; replacement appointed

Clearside BioMedical Inc. said Christy Shaffer stepped down from the position of chairperson but will continue to serve as a member of the board.

The company appointed William Humphries as chairman, effective Feb. 26.

Humphries has served as a director of Clearside since January 2012 and serves as executive vice president at Ortho Dermatologics, a division of Valeant Pharmaceuticals International Inc.

The Alpharetta, Ga.-based company also appointed Brion Raymond to the newly created position of chief commercial officer.

Prior to joining Clearside, Raymond managed a consulting firm that led multiple strategy projects for clinical-stage biotechnology companies.